KeDi-B (02487.HK) : CU-40105 (self-developed external finasteride spray) has received acceptance of the abbreviated new drug application by the National Medical Products Administration.

Zhitemon Financial APP News, Kodite-B (02487.HK) announced that the abbreviated new drug application (ANDA) for the group's CU-40105 (self-developed topical finasteride spray) has been accepted by the China National Medical Products Administration (NMPA), with indications for treating androgenetic alopecia.